Retreatment with immune checkpoint inhibitors in solid tumors: a systematic review

BACKGROUND: A large proportion of patients eventually experience disease progression despite treatment with immune checkpoint inhibitors (ICIs), but subsequent treatment options are limited for this population. Retreatment with the same or different types of ICIs is a possible strategy, but the clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Kaili, Li, Jiarui, Sun, Zhao, Zhao, Lin, Bai, Chunmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705192/
https://www.ncbi.nlm.nih.gov/pubmed/33294036
http://dx.doi.org/10.1177/1758835920975353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705192/
https://www.ncbi.nlm.nih.gov/pubmed/33294036
http://dx.doi.org/10.1177/1758835920975353

Ejemplares similares